GEHC Stock: Price, Forecast, Financials & AI Analysis

Loading...

Loading chart...

High

71.385

Open

69.900

VWAP

70.43

Vol

3.50M

Mkt Cap

31.38B

Low

68.720

Amount

246.25M

EV/EBITDA(TTM)

10.84

Total Shares

456.29M

EV

37.15B

EV/OCF(TTM)

18.70

P/S(TTM)

1.53

GE HealthCare Technologies Inc. is a healthcare solutions provider, innovating medical technology, pharmaceutical diagnostics, and integrated, cloud-first artificial intelligence (AI)-enabled solutions, services and data analytics. Its business segments include Imaging, Advanced Visualization Solutions (AVS), Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). Its Imaging segment offers a portfolio of scanning devices, clinical applications, service capabilities, and digital solutions. Its AVS segment offers ultrasound, image guided therapies, and interventional solutions with a portfolio that spans the continuum of care, including screening, diagnosis, treatment, and monitoring of certain diseases. Its PCS segment consists of patient monitoring, anesthesia delivery and respiratory care, diagnostic cardiology, maternal infant care, and consumables and services. Its PDx segment develops and produces two types of imaging agents: contrast media and radiopharmaceuticals.

Show More

Events Timeline

(ET)

2026-03-26

08:40:00

GE HealthCare Joins COMPASS Consortium with €50.5 Million Budget

2026-03-25 (ET)

2026-03-25

09:10:00

GE HealthCare Showcases Cardiology Innovations at ACC.26

2026-03-23 (ET)

2026-03-23

10:10:00

GE HealthCare's Photonova Spectra Receives FDA Clearance

2026-03-17 (ET)

2026-03-17

09:30:00

GE HealthCare Appoints Stryker CEO Kevin Lobo to Board

2026-03-09 (ET)

2026-03-09

09:10:00

GE HealthCare Announces View Receives FDA 510 Clearance

2026-02-20 (ET)

2026-02-20

07:10:00

nVent Electric Appoints Mellinda Devese as Chief Supply Chain Officer

2026-02-19 (ET)

2026-02-19

09:10:00

GE HealthCare Receives FDA 510(k) Clearance for Three MRI Innovations

News

PRnewswire

03-27PRnewswire

Heart Disease Crisis Fuels AI Diagnostic Platforms

Newsfilter

03-27Newsfilter

Heart Disease Crisis Fuels AI Diagnostic Platforms

NASDAQ.COM

03-27NASDAQ.COM

Butterfly Network and GE Healthcare's AI Technology Competition

Fool

Medical Diagnostic Stocks Benefit from AI Surge

Newsfilter

03-26Newsfilter

COMPASS Initiative Enhances Cardiac Health for Cancer Patients

Newsfilter

03-23Newsfilter

GE HealthCare's Photonova Spectra Receives FDA Clearance

13 Analyst Rating

Wall Street analysts forecast GEHC stock price to rise

8 Buy

5 Hold

0 Sell

Moderate Buy

Current: 0.000

Low

80.00

Averages

92.25

High

105.00

Current: 0.000

Low

80.00

Averages

92.25

High

105.00

Citi

Neutral

downgrade

$88 -> $84

AI Analysis

2026-03-11

Reason

Citi

Price Target

$88 -> $84

AI Analysis

2026-03-11

downgrade

Neutral

Reason

Citi lowered the firm's price target on GE HealthCare to $84 from $88 and keeps a Neutral rating on the shares. The firm adjusted targets in the medical technology group post the Q4 reports. Sector fundamentals remain "healthy" despite the recent volatility, the analyst tells investors in a research note. Citi's top picks are iRhythm and Medtronic.

Argus

Buy

upgrade

$90 -> $95

2026-03-04

Reason

Argus

Price Target

$90 -> $95

2026-03-04

upgrade

Buy

Reason

Argus raised the firm's price target on GE HealthCare to $95 from $90 and keeps a Buy rating on the shares. The firm is positive on the company's solid execution to produce strong financial and operational results in the first two years following its separation from General Electric Co, the analyst tells investors in a research note.

Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for GEHC

Unlock Now

Valuation Metrics

The current forward P/E ratio for GE Healthcare Technologies Inc (GEHC.O) is 17.22, compared to its 5-year average forward P/E of 18.18. For a more detailed relative valuation and DCF analysis to assess GE Healthcare Technologies Inc's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

dotted line Image

5Y Average PE

18.18

Current PE

17.22

Overvalued PE

19.98

Undervalued PE

16.38

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

dotted line Image

5Y Average EV/EBITDA

11.45

Current EV/EBITDA

11.81

Overvalued EV/EBITDA

13.01

Undervalued EV/EBITDA

9.89

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

dotted line Image

5Y Average PS

1.74

Current PS

1.78

Overvalued PS

2.00

Undervalued PS

1.48

Financials

AI Analysis

Annual

Quarterly

Related Community Screener

je veux trader sur le nasdaq 100

Intellectia · 16 candidates

Price: $10.00 - $500.00Analyst Consensus: Strong Buy, Moderate BuyBeta: ModerateRiskIs Index Component: NDX

Ticker

Name

Market Cap$

Apple Inc

3.76T

Alphabet Inc

3.70T

Microsoft Corp

2.98T

Netflix Inc

324.56B

Intuitive Surgical Inc

172.54B

PDD Holdings Inc

142.36B

NASDAQ100 stock with fairly or undervalue

Intellectia · 10 candidates

Analyst Consensus: Strong Buy, Moderate Buy, HoldPe Ttm: 8 - 22P/B Ratio: <= 4.00Is Index Component: NDXEv Ebitda: <= 15

Ticker

Name

Market Cap$

Diamondback Energy Inc

44.13B

PDD Holdings Inc

152.56B

PayPal Holdings Inc

53.15B

Biogen Inc

25.32B

T-Mobile US Inc

211.11B

Cognizant Technology Solutions Corp

41.28B

how do i create a customized screener

Intellectia · 94 candidates

Market Cap: >= 5.00BMarket Cap Category: large, midNet Margin: >= 5.00Beta: ModerateRiskPe Ttm: 10 - 30Return On Equity: >= 10.0%Monthly Average Dollar Volume: >= 1,000,000

Ticker

Name

Market Cap$

PDD Holdings Inc

150.37B

Banco Bilbao Vizcaya Argentaria SA

141.76B

Agnico Eagle Mines Ltd

103.10B

Bank of Montreal

96.25B

PNC Financial Services Group Inc

91.17B

US Bancorp

86.26B

show me stocks that have beta =0.8 Alfa =+5

Intellectia · 25 candidates

Market Cap: 20.00B - 50.00BBeta: ModerateRiskWeekly Average Turnover: >= 1,000,000Pe Ttm: <= 20

Ticker

Name

Market Cap$

D.R. Horton Inc

45.93B

Delta Air Lines Inc

45.02B

Kinross Gold Corp

43.05B

Estee Lauder Companies Inc

42.48B

JD.com Inc

41.25B

Trip.com Group Ltd

40.50B

Whales Holding GEHC

Scout Investments, Inc.

Sofinnova Investment, Inc.

Barrow, Hanley, Mewhinney & Strauss, LLC

Perpetual Limited

Anchor Capital Advisors LLC

Hotchkis and Wiley Capital Management, LLC

Trading Trends

People Also Watch

Frequently Asked Questions

What is GE Healthcare Technologies Inc (GEHC) stock price today?

The current price of GEHC is 71.18 USD — it has increased 3.5

What is GE Healthcare Technologies Inc (GEHC)'s business?

GE HealthCare Technologies Inc. is a healthcare solutions provider, innovating medical technology, pharmaceutical diagnostics, and integrated, cloud-first artificial intelligence (AI)-enabled solutions, services and data analytics. Its business segments include Imaging, Advanced Visualization Solutions (AVS), Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). Its Imaging segment offers a portfolio of scanning devices, clinical applications, service capabilities, and digital solutions. Its AVS segment offers ultrasound, image guided therapies, and interventional solutions with a portfolio that spans the continuum of care, including screening, diagnosis, treatment, and monitoring of certain diseases. Its PCS segment consists of patient monitoring, anesthesia delivery and respiratory care, diagnostic cardiology, maternal infant care, and consumables and services. Its PDx segment develops and produces two types of imaging agents: contrast media and radiopharmaceuticals.

What is the price predicton of GEHC Stock?

Wall Street analysts forecast GEHC stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for GEHC is92.25 USD with a low forecast of 80.00 USD and a high forecast of 105.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is GE Healthcare Technologies Inc (GEHC)'s revenue for the last quarter?

GE Healthcare Technologies Inc revenue for the last quarter amounts to 5.70B USD, increased 7.13

What is GE Healthcare Technologies Inc (GEHC)'s earnings per share (EPS) for the last quarter?

GE Healthcare Technologies Inc. EPS for the last quarter amounts to 1.29 USD, decreased -17.83

How many employees does GE Healthcare Technologies Inc (GEHC). have?

GE Healthcare Technologies Inc (GEHC) has 54000 emplpoyees as of April 01 2026.

What is GE Healthcare Technologies Inc (GEHC) market cap?

Today GEHC has the market capitalization of 31.38B USD.